Information about GlobalPharmacyMeds.to
List of countries where we can ship Vidagliptin:
Latest news releases on Vidagliptin:
Vildagliptin (previously LAF237, trade names Galvus, Zomelis,) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) ...
Vildagliptin is a new oral antidiabetic agent that enhances pancreatic islet cell responsiveness to glucose. An extensive clinical program involving approximately ...
Vildagliptin is a medicine available in a number of countries worldwide. A list of US medications equivalent to Vildagliptin is available on the Drugs.com website.
3 4.2 Posology and method of administration Posology Adults When used as monotherapy, in combination with metformin, in combination with thiazolidinedione,
Vildagliptin is an antidiabetic injection that is used to treat diabetes. For more information about diabetes treatments and vildagliptin visit Patient
Novartis’ Galvus (vildagliptin) is a member of a new class of oral antidiabetic agents known as dipeptidyl peptidase IV inhibitors...Read More...
Galvus 50 mg Tablets - Summary of Product Characteristics (SPC) by Novartis Pharmaceuticals UK Ltd
Vildagliptin (Galvus) is a new class of drugs for the treatment of Type 2 diabetes. This drug reduces blood glucose by enhancing the effects of incretins - hormones ...
Soweit möglich und gebräuchlich, werden SI-Einheiten verwendet. Wenn nicht anders vermerkt, gelten die angegebenen Daten bei Standardbedingungen.
European Union agency responsible for the protection of public and animal health through the scientific evaluation and supervision of medicines.